# Pharmacokinetic Study of Intranasal CT001 in Children 1-17 Years of Age Undergoing Elective Surgical Procedures

> **NCT04897750** · PHASE2 · COMPLETED · sponsor: **Cessatech A/S** · enrollment: 25 (actual)

## Conditions studied

- Analgesia

## Interventions

- **COMBINATION_PRODUCT:** CT001

## Key facts

- **NCT ID:** NCT04897750
- **Lead sponsor:** Cessatech A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-19
- **Primary completion:** 2022-05-16
- **Final completion:** 2022-05-16
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2022-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04897750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04897750, "Pharmacokinetic Study of Intranasal CT001 in Children 1-17 Years of Age Undergoing Elective Surgical Procedures". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04897750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*